Healthtech Startups

Procarta Biosystems develops gene control technology to treat drug-resistant bacterial infections, including MRSA. The company was spun out from the John Innes Centre and Plant Biosciences Limited and focuses on anti-infective therapeutics for the biotech and pharmaceutical sector.

1 investor

Procavea Biotech develops a protein-based molecular delivery platform (nonviral protein cages) to address delivery limitations in RNA therapeutics, with applications also in medical imaging. An ETH Zurich spin-off, it targets the pharmaceutical and biotech sector.

1 investor

1 investor

ProciseDx develops diagnostic technology, including a point-of-care testing platform, drawing on expertise in central lab instrumentation and point-of-care devices. It serves the point-of-care diagnostics market.

1 investor

Proem Behavioral Health provides a digital behavioral health assessment platform and exclusively licensed clinical instruments (including the M.I.N.I.) used to screen, diagnose, monitor and measure outcomes for mental health and substance use disorders. It serves healthcare providers—primary care, pediatrics, behavioral health, FQHCs and SUD clinics—as well as clinical researchers selecting and tracking trial participants.

1 investor

ProEves is a platform for early childhood care and education in India that helps parents discover, verify, and book preschools and daycares through physical centres, digital solutions, and at-home support. The platform operates as part of Pluxee, a global employee benefits company, and lists over 12,700 centres across India.

1 investor

Profionics develops host-response biomarker technology for rapid detection and diagnosis of sepsis. The company serves healthcare providers and operates in the diagnostic and biotech sectors.

1 investor

Profit Matters provides bookkeeping and tax services to healthcare practices, helping owners maximize profits and minimize taxes while delivering accounting expertise. The company focuses on setting up financial systems, fixing accounting errors, maintaining monthly records, and providing strategic financial insights to healthcare business owners.

1 investor

Profound Research develops clinical research solutions and decision-support tools for physicians to improve patient access to innovative medical treatments. The company focuses on supporting care delivery decisions that advance medical innovation and patient outcomes.

1 investor

Profundus develops an ophthalmic retinal camera that uses Multi Conjugate Adaptive Optics (MCAO) with multiple deformable mirrors to capture high-resolution, wide-field images of the retina. The device resolves retinal features down to a few microns and offers higher resolution and a larger field of view than conventional fundus cameras and single-conjugate adaptive optics systems.</parameter> <parameter name="founders">[]

1 investor

ProgenyHealth provides personalized maternity and neonatal intensive care management for health plan members, spanning prenatal care through 12 months postpartum. The company serves payers and physicians with integrated case management, NICU utilization oversight, and claims review services to improve maternal and infant health outcomes while reducing unnecessary healthcare costs.

1 investor

Progressive Dental Marketing provides marketing services, practice development consulting, and staffing support for dental practices seeking to grow their patient base and clinical operations.

1 investor

Progressive NEURO, Inc. develops medical devices for the treatment of ischemic stroke, including products that go beyond traditional aspiration and thrombectomy to improve first-pass efficacy and reduce distal emboli and vessel wall trauma. The company holds seven issued patents covering five different products.

1 investor

Project M is a healthcare platform that uses AI and causal inference to optimize care strategies for individual patients, providing real-time, evidence-based treatment recommendations along with cost and outcome implications. It targets clinical and administrative decision-making to support value-based care, with an initial validated use case in hip fracture treatment and alignment to CMS incentive programs such as TEAM.

1 investor

Prolight Diagnostics develops the Psyros platform, a point-of-care diagnostic system designed to deliver laboratory-quality test results at the patient bedside with speed and cost-effectiveness. The company serves clinical diagnostics markets including traumatic brain injury and cardiac biomarkers.

1 investor

KHIO is a wearable device that applies targeted, drug-free cooling therapy to the forehead to relieve migraines, headaches, muscle tension, and post-workout heat. It offers adjustable cooling levels and a companion app for controlling the device, logging sessions, and tracking symptom patterns.

1 investor

Prolocor is developing diagnostic tests related to atherosclerotic cardiovascular disease and thrombotic risk, including platelet FcγRIIa-based assessment of risk in cancer patients. Its work is oriented toward clinical and medical diagnostics in the United States.

1 investor

Promamec is a Morocco-based medical devices company that distributes equipment and consumables from international brands to healthcare professionals and manufactures gauze bands, medical kits, and sterile drapes at its factory. It serves hospitals, dialysis centers, and other healthcare providers, and offers after-sales service across the medical sector.

1 investor

Promed Bioscience develops, manufactures, and supplies highly purified research and medical grade collagen extracted from animal tissue using proprietary methods. It provides collagen-based formulations, biomaterials, and devices customized for research, clinical, and cosmetic/skincare applications, sold through worldwide channels and partners.

1 investor

Promega provides a portfolio of reporter bioassays used to characterize and develop monoclonal antibody and cell-based therapeutics for drug developers. The assays measure biological functions including Fc effector activity, immune checkpoint modulation, T cell activation, and cytokine signaling.

1 investor

Promera provides design, installation, and product solutions for digital infrastructure environments including data centers and server rooms. The company specializes in airflow management, cooling efficiency, security, structured cabling, and compliance systems for enterprise and colocation facilities.

1 investor

Promis Diagnostics develops noninvasive tests for early detection of colorectal, bladder, and lung cancer using its patented LTE-qMSP technology, which uses methylated DNA as biomarkers via PCR. The company targets patients seeking accessible and affordable cancer screening options.

1 investor

ProMIS Neurosciences is a clinical-stage biotechnology company developing antibody therapeutics that target toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's, ALS, and Parkinson's. The company operates in the biotechnology and neurology therapeutics space.

1 investor

Prompt Health is a cloud-based, AI-powered electronic medical record and practice management platform designed exclusively for outpatient rehabilitation therapy clinics including physical therapy, occupational therapy, speech therapy, pediatric therapy, and chiropractic practices. The platform integrates clinical documentation, scheduling, billing, patient engagement, compliance, and analytics in a single system.

1 investor